Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011;3(4):e00066.
doi: 10.1042/AN20110019.

Peripheral neuropathy in the Twitcher mouse involves the activation of axonal caspase 3

Affiliations
Review

Peripheral neuropathy in the Twitcher mouse involves the activation of axonal caspase 3

Benjamin Smith et al. ASN Neuro. 2011.

Abstract

Infantile Krabbe disease results in the accumulation of lipid-raft-associated galactosylsphingosine (psychosine), demyelination, neurodegeneration and premature death. Recently, axonopathy has been depicted as a contributing factor in the progression of neurodegeneration in the Twitcher mouse, a bona fide mouse model of Krabbe disease. Analysis of the temporal-expression profile of MBP (myelin basic protein) isoforms showed unexpected increases of the 14, 17 and 18.5 kDa isoforms in the sciatic nerve of 1-week-old Twitcher mice, suggesting an abnormal regulation of the myelination process during early postnatal life in this mutant. Our studies showed an elevated activation of the pro-apoptotic protease caspase 3 in sciatic nerves of 15- and 30-day-old Twitcher mice, in parallel with increasing demyelination. Interestingly, while active caspase 3 was clearly contained in peripheral axons at all ages, we found no evidence of caspase accumulation in the soma of corresponding mutant spinal cord motor neurons. Furthermore, active caspase 3 was found not only in unmyelinated axons, but also in myelinated axons of the mutant sciatic nerve. These results suggest that axonal caspase activation occurs before demyelination and following a dying-back pattern. Finally, we showed that psychosine was sufficient to activate caspase 3 in motor neuronal cells in vitro in the absence of myelinating glia. Taken together, these findings indicate that degenerating mechanisms actively and specifically mediate axonal dysfunction in Krabbe disease and support the idea that psychosine is a pathogenic sphingolipid sufficient to cause axonal defects independently of demyelination.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Analysis of Twitcher P30 spinal cord and sciatic nerve
Confocal analysis of MBP and Isolectin-IB4 (IB4) immunostaining in the Twitcher (TWI) (a) and wild-type (WT) (d) spinal cord. Magnification ×100. Double labelling in the TWI sciatic nerve (b, c, magnification ×200) reveals MBP loss and microglia activation compared with WT littermate controls (e, f, magnification ×630). Sciatic nerve MCVs and CNS CCTs of the TWI mouse are compared with WT controls (g).
Figure 2
Figure 2. MBP in the TWI and WT nervous system
Immunoblotting analysis of MBP isoforms (21, 18, 17 and 14 kDa) at P7, 14 and 30 of the TWI spinal cord (a) and sciatic nerve (b) compared with WT controls. Quantifications of results show significant loss of all MBP isoforms at later stages in the disease, while MBP isoforms 18, 17 and 14 are increased at P7 (c).
Figure 3
Figure 3. Immunohistochemistry of TWI spinal cord at P0
Active caspase 3 is visible in the TWI spinal cord (a). Caspase 3 is visible in neuronal processes (b) and cell bodies (c). This is compared with normal caspase 3 activity observed in the P0 WT mice (d). Quantifications show elevated caspase 3 levels at birth (e). Magnifications (a, d) ×50; (b, c) ×400.
Figure 4
Figure 4. Active caspase 3 in the TWI spinal cord
Active caspase 3 (aCasp3) (green) in longitudinal sections of the P30 TWI spinal cord (a) compared with WT (b). Magnification ×200. Active caspase 3 in transverse sections of the ventral funiculus region of the spinal cord shows caspase 3 in the TWI (c) and WT (d). Magnification ×400. Active caspase 3 is localized to some axons ensheathed with MBP (red). Magnification ×1000.
Figure 5
Figure 5. Immunoblot analysis of active caspase 3 in the spinal cord
Inactive (iCaspase 3) and active caspase 3 (aCaspase 3) levels are shown in WT and TWI spinal cord tissue at P7, 14 and 30 (a). Quantifications of fold change in active/inactive caspase 3 levels are shown (b). n = 3.
Figure 6
Figure 6. Active caspase 3 in the TWI sciatic nerve
Caspase 3 (green) is localized to nerve fibres with different stages of MBP loss (red) in the P15 TWI mouse (a, inset) compared with P15 WT mice (b). This continues in the P30 TWI (c) compared with controls (d). Background levels for TWI (A-488) (e) and TWI (A-546) (f) animals are also shown. Magnification ×200.
Figure 7
Figure 7. Immunoblot analysis of active caspase 3 in the sciatic nerve
Inactive (iCaspase 3) and active caspase 3 (aCaspase 3) levels are shown in WT and TWI sciatic nerve tissue at P7, 14 and 30 (a). Quantifications of fold change in active/inactive caspase 3 levels are shown (b). n = 3.
Figure 8
Figure 8. Caspase 3 in vitro
Immunoblot analysis of inactive and active caspase 3 levels in NSC34 cells treated with 1 and 5 μM psychosine (PSY) where 30 μM C6-ceramide (C6-C) serves as the positive control (a). Quantifications of fold change in active/inactive caspase 3 levels are shown (b) (n = 2). Active caspase 3 (aCasp3, green) is visible in 5 μM 24 PSY treated cells for 2 h (c) compared with vehicle controls also labelled with neurofilament light chain (NF-L, red). Magnification ×200. (d). DNA fragmentation assay shows an increase in DNA fragments when cells are treated with 1 and 5 μM PSY compared with untreated (UT), vehicle (VH) and 1 μM d-sphingosine (Sph) negative controls where C6-C serves as a positive control (e).

References

    1. Ahmed Z, Doward AI, Pryce G, Taylor DL, Pocock JM, Leonard JP, Baker D, Cuzner ML. A role for caspase-1 and -3 in the pathology of experimental allergic encephalomyelitis: inflammation versus degeneration. Am J Pathol. 2002;161:1577–1586. - PMC - PubMed
    1. Aicardi J. The inherited leukodystrophies: a clinical overview. J Inherit Metab Dis. 1993;16:733–743. - PubMed
    1. Barbarese E, Carson JH, Braun PE. Accumulation of the four myelin basic proteins in mouse brain during development. J Neurochem. 1978;31:779–782. - PubMed
    1. Bird TD, Farrell DF, Sumi SM. Brain lipid composition of the shiverer mouse: genetic defect in myelin development. J Neurochem. 1978;31:387–391. - PubMed
    1. Bjartmar C, Yin X, Trapp BD. Axonal pathology in myelin disorders. J Neurocytol. 1999;28:383–395. - PubMed

Publication types

MeSH terms